A Study to Assess the Safety, Tolerability and Pharmacokinetics of Viaca (Sildenafil + Cabergoline) Compared With Sildenafil and Cabergoline

NCT07732387 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Erectile Dysfunctions
Healthy Volunteer

Interventions

DRUG: Viaca
DRUG: Sildenafil 50 mg
DRUG: Cabergoline 0.5 MG

Sponsor

Yanping Kong

Collaborators

[object Object]